Demonstration of the Effectiveness of Monte Carlo-Based Data Sets with the Simplified Approach for Shielding Design of a Laboratory with the Therapeutic Level Proton Beam

다국어 초록 (Multilingual Abstract)

Background: There are several proton therapy facilities in operation or planned in Taiwan, and these facilities are anticipated to not only treat cancer but also provide beam services to the industry or academia. The simplified approach based on the Monte Carlo-based data sets (source terms and attenuation lengths) with the point-source line-of-sight approximation is friendly in the design stage of the proton therapy facilities because it is intuitive and easy to use. The purpose of this study is to expand the Monte Carlo-based data sets to allow the simplified approach to cover the application of proton beams more widely.Materials and Methods: In this work, the MCNP6 Monte Carlo code was used in three simulations to achieve the purpose, including the neutron yield calculation, Monte Carlo-based data sets generation, and dose assessment in simple cases to demonstrate the effectiveness of the generated data sets.Results and Discussion: The consistent comparison of the simplified approach and Monte Carlo simulation results show the effectiveness and advantage of applying the data set to a quick shielding design and conservative dose assessment for proton therapy facilities.Conclusion: This study has expanded the existing Monte Carlo-based data set to allow the simplified approach method to be used for dose assessment or shielding design for beam services in proton therapy facilities. It should be noted that the default model of the MCNP6 is no longer the Bertini model but the CEM (cascade-exciton model), therefore, the results of the simplified approach will be more conservative when it was used to do the double confirmation of the final shielding design.

참고문헌 (Reference)

1 Sheu RJ, "Source terms and attenuation lengths for estimating shielding requirements or dose analyses of proton therapy accelerators" 105 (105): 128-139, 2013

2 Agosteo S, "Shielding data for 100–250 MeV proton accelerators : attenuation of secondary radiation in thick iron and concrete/iron shields" 266 (266): 3406-3416, 2008

3 Lai BL, "Shielding analysis of proton therapy accelerators:a demonstration using Monte Carlo-generated source terms and attenuation lengths" 108 (108): S84-S93, 2015

4 Agosteo S, "Radiation protection constraints for use of proton and ion accelerators in medicine" 137 (137): 167-186, 2009

5 Particle Therapy Co-Operative Group, "Particle therapy centers and patient statistics" Particle Therapy Co-Operative Group

6 Particle Therapy Co-Operative Group, "PTCOG Publications Sub-Committee Task Group on shielding design and radiation safety of charged" Particle Therapy Co-Operative Group

7 Pelliccioni M, "Overview of fluence-to-effective dose and fluenceto-ambient dose equivalent conversion coefficients for high energy radiation calculated using the FLUKA code" 88 (88): 279-297, 2000

8 Meier MM, "Neutron yields from stopping-and near-stopping-length targets for 256-MeV protons" 104 (104): 339-363, 1990

9 Iwamoto Y, "Measurement of thick target neutron yields at 0° bombarded with 140, 250 and 350 MeV protons" 593 (593): 298-306, 2008

10 Goorley T, "Initial MCNP6 release overview" 180 (180): 298-315, 2012

11 Vlachoudis V, "FLAIR: a powerful but user friendly graphical interface for FLUKA" Saratoga Springs 2009

12 "Conversion coefficients for use in radiological protection against external radiation. Adopted by the ICRP and ICRU in September 1995" 26 (26): 1-205, 1996